Stock Earnings

Question 1

What are Genocea Biosciences Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Genocea Biosciences Inc has a total asset of $55, Net loss of $-33

Question 2

What are the key financial ratios for GNCAQ?

Accepted Answer

Genocea Biosciences Inc's Current ratio is 1.96, has a Net margin is -3,300, sales per share of $0.01.

Question 3

How is Genocea Biosciences Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Genocea Biosciences Inc data is not available.

Question 4

Is Genocea Biosciences Inc profitable?

Accepted Answer

no, according to the latest financial statements, Genocea Biosciences Inc has a net loss of $-33

Question 5

Does Genocea Biosciences Inc have any liabilities?

Accepted Answer

yes, Genocea Biosciences Inc has liability of 28

Question 6

How many outstanding shares for Genocea Biosciences Inc?

Accepted Answer

Genocea Biosciences Inc has a total outstanding shares of 58.22

Breakdown	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	1	1	--	0
Revenue Growth (YoY)	0%	--	--	--
Cost of Revenue	--	--	--	--
Gross Profit	--	--	--	--
Selling, General & Admin	14	14	--	14
Research & Development	39	33	--	25
Operating Expenses	53	48	--	39
Other Non Operating Income (Expenses)	0	-4	--	-2
Pretax Income	-33	-43	--	-27
Income Tax Expense	--	--	--	--
Net Income	-33	-43	--	-27
Net Income Growth	-23%	--	--	--
Shares Outstanding (Diluted)	68.57	44.43	--	10.32
Shares Change (YoY)	54%	--	--	--
EPS (Diluted)	-0.48	-0.98	--	-2.69
EPS Growth	-51%	--	--	--
Free Cash Flow	-48	-44	-38	--
Free Cash Flow Per Share	-0.69	-0.99	--	--
Gross Margin	--	--	--	--
Operating Margin	-5,200%	-4,600%	--	0%
Profit Margin	-3,300%	-4,300%	--	0%
Free Cash Flow Margin	-4,800%	-4,400%	--	--
EBITDA	-51	-45	--	--
EBITDA Margin	-5,100%	-4,500%	--	--
D&A For EBITDA	1	1	1	--
EBIT	-52	-46	--	-39
EBIT Margin	-5,200%	-4,600%	--	0%
Effective Tax Rate	--	--	--	--

Genocea Biosciences Inc (GNCAQ) Price